Background: Cystic Fibrosis (CF) patients are vulnerable to airway colonization with Pseudomonas aeruginosa. In case eradication fails after antibiotic treatment, patients become chronically colonized with P. aeruginosa, with recurrent pulmonary exacerbation, for which patients typically are hospitalized for 2 weeks and receive intravenous antibiotic treatment. Normally, improvement of the patients ’ health is established. Aim: Determination of the correspondence between patient improvement and changes of the P. aeruginosa and total bacterial load in the sputum. Methods: Eighteen CF patients with exacerbation were included for a total of 27 hospitalization episodes. At day 1, 8 and 15, inflammation and lung function parameters were determin...
SummaryCommercial availability of more than one inhaled antibiotic for the management of chronic Pse...
Background: Pseudomonas aeruginosa and Aspergillus fumigatus frequently co-colonise the airways of p...
BACKGROUND: Pseudomonas aeruginosa is the major respiratory pathogen causing severe lung infections ...
BACKGROUND: Cystic Fibrosis (CF) patients are vulnerable to airway colonization with Pseudomonas aer...
Background: Cystic Fibrosis (CF) patients are vulnerable to airway colonization with Pseudomonas aer...
Background: Cystic Fibrosis (CF) patients are vulnerable to airway colonization with Pseudomonas aer...
, with recurrent pulmonary exacerbation, for which patients typically are hospitalized for 2 weeks a...
AbstractBackgroundIntravenous antibiotics for pulmonary exacerbations (PEs) of cystic fibrosis (CF) ...
Background: Intravenous antibiotics for pulmonary exacerbations (PEs) of cystic fibrosis (CF) usuall...
Introduction: In CF, infective pulmonary exacerbations are common. Despite this, significant aspects...
AbstractBackgroundIntravenous antibiotics for pulmonary exacerbations (PEs) of cystic fibrosis (CF) ...
1. To compare the photyic characteristics of persistent vs. eradicated Pseudomonas aeruginosa in cys...
Background: Although anti-pseudomonal antibiotics are routinely used in the treatment of acute respi...
Respiratory failure secondary to chronic bronchiectasis is the cause of death in more than 90% of pa...
Background: A diverse array of bacterial species is present in the CF airways, in addition to those ...
SummaryCommercial availability of more than one inhaled antibiotic for the management of chronic Pse...
Background: Pseudomonas aeruginosa and Aspergillus fumigatus frequently co-colonise the airways of p...
BACKGROUND: Pseudomonas aeruginosa is the major respiratory pathogen causing severe lung infections ...
BACKGROUND: Cystic Fibrosis (CF) patients are vulnerable to airway colonization with Pseudomonas aer...
Background: Cystic Fibrosis (CF) patients are vulnerable to airway colonization with Pseudomonas aer...
Background: Cystic Fibrosis (CF) patients are vulnerable to airway colonization with Pseudomonas aer...
, with recurrent pulmonary exacerbation, for which patients typically are hospitalized for 2 weeks a...
AbstractBackgroundIntravenous antibiotics for pulmonary exacerbations (PEs) of cystic fibrosis (CF) ...
Background: Intravenous antibiotics for pulmonary exacerbations (PEs) of cystic fibrosis (CF) usuall...
Introduction: In CF, infective pulmonary exacerbations are common. Despite this, significant aspects...
AbstractBackgroundIntravenous antibiotics for pulmonary exacerbations (PEs) of cystic fibrosis (CF) ...
1. To compare the photyic characteristics of persistent vs. eradicated Pseudomonas aeruginosa in cys...
Background: Although anti-pseudomonal antibiotics are routinely used in the treatment of acute respi...
Respiratory failure secondary to chronic bronchiectasis is the cause of death in more than 90% of pa...
Background: A diverse array of bacterial species is present in the CF airways, in addition to those ...
SummaryCommercial availability of more than one inhaled antibiotic for the management of chronic Pse...
Background: Pseudomonas aeruginosa and Aspergillus fumigatus frequently co-colonise the airways of p...
BACKGROUND: Pseudomonas aeruginosa is the major respiratory pathogen causing severe lung infections ...